2021
DOI: 10.1002/nbm.4503
|View full text |Cite
|
Sign up to set email alerts
|

Improved method for post‐processing correction of B1 inhomogeneity in glutamate‐weighted CEST images of the human brain

Abstract: Glutamate-weighted CEST (gluCEST) imaging is nearly unique in its ability to provide non-invasive, spatially resolved measurements of glutamate in vivo. In this article, we present an improved correction for B 1 inhomogeneity of gluCEST images of the human brain. Images were obtained on a Siemens 7.0 T Terra outfitted with a single-volume transmit/32-channel receive phased array head coil. Numerical Bloch-McConnell simulations, fitting and data processing were performed using inhouse code written in MATLAB and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
28
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

6
1

Authors

Journals

citations
Cited by 13 publications
(28 citation statements)
references
References 25 publications
0
28
0
Order By: Relevance
“…Average gluCEST values range from 7-9%, typical for gray matter regions in healthy subjects using this protocol 31,32 . Interestingly, there appears to be some anatomic variability in gluCEST values in this slice at baseline; however, we did not attempt to further interpret these results, given the limited number of subjects.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Average gluCEST values range from 7-9%, typical for gray matter regions in healthy subjects using this protocol 31,32 . Interestingly, there appears to be some anatomic variability in gluCEST values in this slice at baseline; however, we did not attempt to further interpret these results, given the limited number of subjects.…”
Section: Resultsmentioning
confidence: 99%
“…CEST-weighted images were corrected for the B0 field distribution using the B0 image generated by the WASSR scan, as described in 30 . CEST images were corrected for B1 inhomogeneity using a recently developed procedure based on B1 and T1 mapping 32 . T1 and T2 weighted fullbrain structural images were used for segmentation by Freesurfer's 'Recon All' function 39 (Freesurfer: Martinos Center for Biomedical Imaging, Charlestown, MA, USA).…”
Section: Data Processing and Analysismentioning
confidence: 99%
“…So, while the dielectric pads were of great benefit in correcting inhomogeneities, they do not eliminate the need for adequate post-processing, as clearly illustrated in the work that originally presented this type of post-processing correction method. 14 Also, while largely effective across the whole brain, a difference in dielectric pad effectiveness was observed in tissue segmentation analysis between GM and WM regions. In combination with inherent B 1 inhomogeneities present at ultra-high fields, a portion of the present B 1 drop off was due to the oblique slice taken in alignment with the hippocampus.…”
Section: Discussionmentioning
confidence: 99%
“…GluCEST‐weighted images were corrected for the B 0 field distribution using the acquired WASSR 26 and relative B 1 + field maps 27 . A further post‐processing correction strategy, as described in Cember et al, 14 was used to correct gluCEST contrast and quantitative accuracy in images acquired with and without dielectric padding. This post‐processing correction was used as a standard step when analyzing gluCEST data in later sections.…”
Section: Methodsmentioning
confidence: 99%
“…The first is to interpolate a value corresponding to rB 1 (relative B 1 , defined as real B 1 /nominal B 1 ) = 1 on the MTR-rB 1 plane or Z-rB 1 plane pixel by pixel [ 88 ]. The second is to fit the data on the MTR-rB 1 or Z-rB 1 plane with a selectively constructed function for each pixel group, divided based on the tissue types of T 1 values [ 89 , 90 ]. The third is to perform Bloch-McConnell fitting on the Z-spectra and generate new Z-spectra with B 1 values that are corrected from real ones to nominal ones [ 91 ].…”
Section: Technical Issues For Non-brain Tumor Imagingmentioning
confidence: 99%